The U.S. Fifth Circuit Court of Appeals Is Poised to Address Emergency Abortions and the Scope of EMTALA’s Preemption of State Abortion Laws

17 Maret 2023

On 10 March 2023, the U.S. Department of Justice (the DOJ) appealedto the Fifth Circuit Court of Appeals an amended final decision by the Northern District of Texas (the Texas District Court) that struck down U.S. Department of Health and Human Services (HHS) guidance regarding the Emergency Medical Treatment and Labor Act (EMTALA).  Specifically, the HHS guidance addressed EMTALA’s preemption of state abortion laws.

In the wake of the U.S. Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization,numerous state abortion laws took effect that established various parameters (e.g., reinstating pre-Roe statutes, establishing new restrictions, and providing exceptions) for when abortions are permissible in emergency situations. Consequently, stakeholders questioned whether state laws that draw emergency exceptions more narrowly than how EMTALA defines an emergency medical condition are preempted by EMTALA. Shortly after the Dobbs decision, HHS laid out its position in a 11 July 2022 memorandum issued to state survey directors (the EMTALA memo) that asserted, among other things,that state laws purporting to limit abortion services more narrowly than provided under EMTALA are preempted.4  

Three days after HHS issued the EMTALA memo, the Texas Attorney General (AG) filed a federal complaint in the Texas District Court seeking a declaratory judgment that HHS had acted beyond its authority in issuing the EMTALA memo, as well as an injunction seeking to prevent enforcement of the EMTALA memo.The Texas District Court agreed with the Texas AG’s arguments, reasoning that EMTALA contains “equal obligations” to both a pregnant woman and her unborn child and, therefore, does not directly conflict with Texas state law. Accordingly, the Texas District Court granted Texas’ request for an injunction, in part, in a preliminary order issued 23 August 2022.6

This preliminary order led to an interlocutory appeal by the DOJ to the Fifth Circuit; however, to create a procedurally more straightforward path to appeal, the Texas District Court ultimately issued an amended final decision on 13 January 2023 affirming the preliminary order. Accordingly, the federal government dismissed its interlocutory appeal, and it has now appealed the amended final decision.

The outcome of this appeal could significantly impact how hospitals, health systems, and other providers deliver emergency abortion care across the country. HHS continues to stand behind the EMTALA memo, which has only been enjoined in the state of Texas to date,stating that it would investigate reports or complaints regarding an EMTALA violation and “will not hesitate” to refer states attempting to prohibit providers from offering emergency care consistent with EMTALA to the DOJ “to take appropriate legal action.”8  

At the same time, related federal litigation is underway in the District of Idaho, where, in a preliminary order issued on 24 August 2022—one day after the Texas District Court’s preliminary order— the Idaho District Court reached a contrary decision to the Texas District Court, finding that EMTALA preempted an Idaho state law that provided only a narrow affirmative defense to criminal liability for providing emergency abortion care. As of the publication of this alert, the Idaho District Court case has a motion for reconsideration filed by the Idaho AG pending, and the Idaho State Legislature has filed an interlocutory appeal to the Ninth Circuit seeking to overturn a lower court decision disallowing them from intervening in the case. Ultimately, though, it is anticipated that once a final decision is issued by the Idaho District Court, that decision will likewise be appealed to the Ninth Circuit, which could set up a showdown between the Fifth and Ninth Circuits as to the scope of EMTALA preemption and, quite possibly, lead to another U.S. Supreme Court case concerning abortion.

K&L Gates will continue to monitor these federal cases and their impact on EMTALA and will provide updates as this issue unfolds.